Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. (Q52920250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

5 November 2019

main subject

0 references

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Stefano Bastianello

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Claudio Gasperini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A Paolillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Pozzilli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Giugni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Mainero

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Giuliani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V Tomassini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

5 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

85-91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10727693%20AND%20SRC:MED&resulttype=core&format=json

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

A spinal cord MRI study of benign and secondary progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

The pathological evolution of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Cerebral disconnection in multiple sclerosis. Relationship to atrophy of the corpus callosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Statistical methods for assessing agreement between two methods of clinical measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Cranial computed tomography in the diagnosis of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Neuroimaging in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Magnetic resonance imaging correlates of dementia in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Axonal transection in the lesions of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Cerebral dominance, sex, and callosal size in MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8

Scales for rating impairment in multiple sclerosis: a critique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900259-8